SCHEMBL6540564

SCHEMBL6540564

O=S(=O)(c1ccc(O)cc1)c1ccc(CCN(Cc2ccccc2)C[C@H](O)c2cccc(Cl)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 3/20 0.43
OPRM1 P35372 2/20 0.43
OPRD1 P41143 2/20 0.43
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
SPPL2A Q8TCT8 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
ADRB3 P13945 6/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
KCNH2 Q12809 1/20 0.39
BCHE P06276 2/20 0.39
TAS2R14 Q9NYV8 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6540670 1.00 OPRK1 (0.43) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6540568 1.00 OPRK1 (0.43) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6539818 0.95 ADRB3 (0.41) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6539821 0.95 ADRB3 (0.41) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6540503 0.94 OPRK1 (0.41) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6540495 0.94 OPRK1 (0.41) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6540160 0.93 OPRK1 (0.46) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6540170 0.93 OPRK1 (0.46) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6540171 0.93 OPRK1 (0.46) OPRK1OPRM1OPRD1PSEN1PSEN2
SCHEMBL6540353 0.93 TAS2R14 (0.42) PSEN1PSEN2SPPL2AAPH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138462-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-07-15 US disclosed
US-20040106653-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-03 US disclosed
EP-1389185-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-02-18 EP disclosed
WO-2002094770-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138462-A1 Aminoalcohol derivatives BPHL, FANCD2, HRH2 OPRK1 89/4885OPRM1 180/4885OPRD1 68/4885
US-20040106653-A1 Aminoalcohol derivatives FANCD2, FANCI, HRH2 OPRK1 338/4885OPRM1 288/4885OPRD1 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.